Legis Daily

To amend title XIX of the Social Security Act to provide incentives for education on the risk of renal medullary carcinoma in individuals who are receiving medical assistance under such title and who have Sickle Cell Disease.

USA115th CongressHR-148| House 
| Updated: 1/25/2017
Al Green

Al Green

Democratic Representative

Texas

Cosponsors (1)
Dennis A. Ross (Republican)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Byron Nash Renal Medullary Carcinoma Awareness Act of 2017 This bill amends title XIX (Medicaid) of the Social Security Act to pay states 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jan 3, 2017
Introduced in House
Jan 3, 2017
Referred to the House Committee on Energy and Commerce.
Jan 25, 2017
Referred to the Subcommittee on Health.
  • January 3, 2017
    Introduced in House


  • January 3, 2017
    Referred to the House Committee on Energy and Commerce.


  • January 25, 2017
    Referred to the Subcommittee on Health.

Health

CancerDigestive and metabolic diseasesHealth promotion and preventive careMedicaid

To amend title XIX of the Social Security Act to provide incentives for education on the risk of renal medullary carcinoma in individuals who are receiving medical assistance under such title and who have Sickle Cell Disease.

USA115th CongressHR-148| House 
| Updated: 1/25/2017
Byron Nash Renal Medullary Carcinoma Awareness Act of 2017 This bill amends title XIX (Medicaid) of the Social Security Act to pay states 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jan 3, 2017
Introduced in House
Jan 3, 2017
Referred to the House Committee on Energy and Commerce.
Jan 25, 2017
Referred to the Subcommittee on Health.
  • January 3, 2017
    Introduced in House


  • January 3, 2017
    Referred to the House Committee on Energy and Commerce.


  • January 25, 2017
    Referred to the Subcommittee on Health.
Al Green

Al Green

Democratic Representative

Texas

Cosponsors (1)
Dennis A. Ross (Republican)

Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
CancerDigestive and metabolic diseasesHealth promotion and preventive careMedicaid